The American Hospital Association, the Association of American Medical Colleges, Americas Essential Hospitals and others filed suit on Nov. 13,over the Centers for Medicare & Medicaid Services' decision to slash funding for the program by 28 percent.
Federal officials are exploring how beneficiaries could get a share of certain behind-the-scenes fees and discounts negotiated by insurers and pharmacy benefit managers, or PBMs, who together administer Medicares Part D drug program.
With the price of a crucial diabetes drug skyrocketing, at least five states and a federal prosecutor are demanding information from insulin manufacturers and the pharmaceutical industrys financial middlemen.